Pharma’s data and analytics market forecast to reach to $2.1bn by 2028
Data content management will drive the growing global data and analytics market in the pharmaceutical sector, which will reach a…
All articles by Eve Thomas
Eve Thomas
Eve Thomas is a reporter writing across a variety of sectors with a specific focus on thematic intelligence. She has a BA in English Literature from the University of Sheffield and an MSt in English from Oxford University.
-
-
Novo Nordisk invests $1.2bn in new Denmark facility
Denmark-based pharma giant Novo Nordisk has announced plans to invest DKr8.5bn ($1.2bn) to establish a new production facility in Odense,…
-
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
In an open letter, 77 Nobel laureates have “strongly” urged members of the US Senate to reject Donald Trump’s nomination…
-
Vifor Pharma offers £23m to NHS to resolve CMA investigation
The UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to…
-
FDA shares new draft guidance for accelerated approval
The US Food and Drug Administration (FDA) has published new draft guidance for its Accelerated Approval Program, which provides a…
-
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Merus’ Bizengri (zenocutuzumab-zbco) has received accelerated approval from the US Food and Drug Administration (FDA), marking “an important milestone” in…
-
Trump 2.0 could see a rise in biopharmaceutical M&A deals
Trump’s return to the White House will mean a shift in personnel at the US Federal Trade Commission (FTC), which…
-
EMA launches ESMP for better management of drug shortages in EU
The first version of the European Shortages Monitoring Platform (ESMP) has gone live to help marketing authorisation holders (MAHs) report…
-
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Having promised to “Make America Healthy Again”, the administration in Trump’s second presidency looks set to shake up the health…
-
Digital transformation expected to shorten drug development timelines
A recent survey found that 82% of pharmaceutical industry professionals believe that digital transformation will either significantly or moderately shorten…